aspirin has been researched along with Neurilemmoma in 2 studies
Aspirin: The prototypical analgesic used in the treatment of mild to moderate pain. It has anti-inflammatory and antipyretic properties and acts as an inhibitor of cyclooxygenase which results in the inhibition of the biosynthesis of prostaglandins. Aspirin also inhibits platelet aggregation and is used in the prevention of arterial and venous thrombosis. (From Martindale, The Extra Pharmacopoeia, 30th ed, p5)
acetylsalicylate : A benzoate that is the conjugate base of acetylsalicylic acid, arising from deprotonation of the carboxy group.
acetylsalicylic acid : A member of the class of benzoic acids that is salicylic acid in which the hydrogen that is attached to the phenolic hydroxy group has been replaced by an acetoxy group. A non-steroidal anti-inflammatory drug with cyclooxygenase inhibitor activity.
Neurilemmoma: A neoplasm that arises from SCHWANN CELLS of the cranial, peripheral, and autonomic nerves. Clinically, these tumors may present as a cranial neuropathy, abdominal or soft tissue mass, intracranial lesion, or with spinal cord compression. Histologically, these tumors are encapsulated, highly vascular, and composed of a homogenous pattern of biphasic fusiform-shaped cells that may have a palisaded appearance. (From DeVita Jr et al., Cancer: Principles and Practice of Oncology, 5th ed, pp964-5)
| Excerpt | Relevance | Reference |
|---|---|---|
| "Aspirin has also been associated with decreased VS growth in animal studies." | 1.91 | Metformin Reduces Tumor Growth in a Murine Flank Schwannoma Model. ( Burns, A; Hartman, Y; Hunter, JB; Killeen, DE; Lora Gonzalez, MA; Manickavel, S; Walsh, E; Warram, J, 2023) |
| "Aspirin use was not associated with VS tumor growth, presenting tumor diameter, or mean VS growth rate." | 1.46 | Vestibular Schwannoma Growth With Aspirin and Other Nonsteroidal Anti-inflammatory Drugs. ( Bennett, ML; Haynes, DS; Hunter, JB; O'Connell, BP; Rivas, A; Thompson, RC; Wanna, GB, 2017) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Manickavel, S | 1 |
| Hartman, Y | 1 |
| Burns, A | 1 |
| Lora Gonzalez, MA | 1 |
| Warram, J | 1 |
| Walsh, E | 1 |
| Hunter, JB | 2 |
| Killeen, DE | 1 |
| O'Connell, BP | 1 |
| Wanna, GB | 1 |
| Bennett, ML | 1 |
| Rivas, A | 1 |
| Thompson, RC | 1 |
| Haynes, DS | 1 |
2 other studies available for aspirin and Neurilemmoma
| Article | Year |
|---|---|
Metformin Reduces Tumor Growth in a Murine Flank Schwannoma Model.
Topics: Animals; Aspirin; Metformin; Mice; Mice, Nude; Neurilemmoma; Neuroma, Acoustic; Rats | 2023 |
Vestibular Schwannoma Growth With Aspirin and Other Nonsteroidal Anti-inflammatory Drugs.
Topics: Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Cyclooxygenase 2; Female; Humans; Mag | 2017 |